How would Henry's treatment course align with the recent updates to the NCCN guidelines?
Metastatic Pancreatic Cancer: Case 2
Henry R was diagnosed with adenocarcinoma in the body of the pancreas when he was 64 years old, following rapid weight loss, abdominal pains, and the development of venous thrombosis.
- At diagnosis, measurable distant lymph node, liver, and lung metastases were observed
- His CA19-9 level was 2760 U/ml and his concentration of albumin was 28 g/L. His ECOG performance status was 1.
Upfront treatment was administered with nab-paclitaxel and gemcitabine, which lasted for 4months:
- At the time of progression, pain levels had increased interfering with daily activity and raising the ECOG performance status to a 2.
- At this point, second-line therapy was initiated with liposomal irinotecan, fluorouracil, and folinic acid.